Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for ORIC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 404.68M
March 31, 2026 436.76M
December 31, 2025 411.00M
September 30, 2025 431.19M
June 30, 2025 346.86M
March 31, 2025 242.86M
December 31, 2024 276.73M
September 30, 2024 302.07M
June 30, 2024 328.91M
March 31, 2024 350.79M
December 31, 2023 254.69M
September 30, 2023 274.34M
June 30, 2023 291.82M
March 31, 2023 226.65M
Date Value
December 31, 2022 250.36M
September 30, 2022 238.00M
June 30, 2022 259.68M
March 31, 2022 275.06M
December 31, 2021 302.06M
September 30, 2021 314.18M
June 30, 2021 268.23M
March 31, 2021 283.96M
December 31, 2020 299.00M
September 30, 2020 191.66M
June 30, 2020 201.52M
March 31, 2020 85.06M
December 31, 2019 94.09M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 1.743B
Alnylam Pharmaceuticals, Inc. 5.559B
Anika Therapeutics, Inc. 183.47M
Savara, Inc. 192.14M
Vericel Corp. 502.87M

Total Assets (Quarterly) Related Metrics